Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Prepaid Assets (2016 - 2025)

NovaBay Pharmaceuticals (NBY) has disclosed Prepaid Assets for 15 consecutive years, with $11000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Prepaid Assets fell 95.69% to $11000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $11000.0, a 95.69% decrease, with the full-year FY2024 number at $16000.0, down 93.75% from a year prior.
  • Prepaid Assets was $11000.0 for Q2 2025 at NovaBay Pharmaceuticals, down from $571000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $778000.0 in Q4 2021 to a low of $11000.0 in Q2 2025.
  • A 5-year average of $303538.5 and a median of $255000.0 in 2024 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 181.06% in 2024, then plummeted 95.69% in 2025.
  • NovaBay Pharmaceuticals' Prepaid Assets stood at $778000.0 in 2021, then decreased by 28.02% to $560000.0 in 2022, then tumbled by 54.29% to $256000.0 in 2023, then crashed by 93.75% to $16000.0 in 2024, then crashed by 31.25% to $11000.0 in 2025.
  • Per Business Quant, the three most recent readings for NBY's Prepaid Assets are $11000.0 (Q2 2025), $571000.0 (Q1 2025), and $16000.0 (Q4 2024).